Comera Life Sciences Holdings, Inc. (CMRA)

USD 0.0

(-50.0%)

Long Term Debt Summary of Comera Life Sciences Holdings, Inc.

  • Comera Life Sciences Holdings, Inc.'s latest annual long term debt in 2022 was 120.3 Thousand USD , down -40.3% from previous year.
  • Comera Life Sciences Holdings, Inc.'s latest quarterly long term debt in 2023 Q2 was - USD , down -100.0% from previous quarter.
  • Comera Life Sciences Holdings, Inc. reported annual long term debt of 201.5 Thousand USD in 2021, up 25.48% from previous year.
  • Comera Life Sciences Holdings, Inc. reported annual long term debt of 160.58 Thousand USD in 2020, down 0.0% from previous year.
  • Comera Life Sciences Holdings, Inc. reported quarterly long term debt of 53.66 Thousand USD for 2023 Q1, down -55.39% from previous quarter.
  • Comera Life Sciences Holdings, Inc. reported quarterly long term debt of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Comera Life Sciences Holdings, Inc. (2022 - 2020)

Historical Annual Long Term Debt of Comera Life Sciences Holdings, Inc. (2022 - 2020)

Year Long Term Debt Long Term Debt Growth
2022 120.3 Thousand USD -40.3%
2021 201.5 Thousand USD 25.48%
2020 160.58 Thousand USD 0.0%

Peer Long Term Debt Comparison of Comera Life Sciences Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD 89.289%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD 90.689%
Biora Therapeutics, Inc. 43.73 Million USD 99.725%
Bio-Path Holdings, Inc. 10 Thousand USD -1103.02%
Better Therapeutics, Inc. 10.34 Million USD 98.837%
Calithera Biosciences, Inc. 136 Thousand USD 11.543%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 98.616%
Evelo Biosciences, Inc. 48.87 Million USD 99.754%
Evolutionary Genomics, Inc. 3.74 Million USD 96.787%
Finch Therapeutics Group, Inc. 28.4 Million USD 99.576%
Galera Therapeutics, Inc. 151.04 Million USD 99.92%
Innovation1 Biotech Inc. 218.99 Thousand USD 45.067%
Kiromic BioPharma, Inc. 911.5 Thousand USD 86.802%
Molecular Templates, Inc. 9.74 Million USD 98.765%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 93.573%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 99.369%
Panbela Therapeutics, Inc. 4.19 Million USD 97.132%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 99.885%
Statera Biopharma, Inc. 11.43 Million USD 98.948%
TRACON Pharmaceuticals, Inc. 732 Thousand USD 83.565%
Trevena, Inc. 35.23 Million USD 99.659%
Vaxxinity, Inc. 13.26 Million USD 99.093%
Vaccinex, Inc. 26 Thousand USD -362.7%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%